-
Topics
- Academics
- Accreditation
- Addiction
- Allergies
- Alzheimer's
- Artificial Intelligence
- Awards & Recognition
- Behavioral Health
- Breast Health
- Cardiology
- Career Opportunities
- Clinical Trials
- COVID-19
- Dermatology
- Diabetes
- Diet & Nutrition
- Diversity
- Ear Nose & Throat
- Education
- Emergency Medicine
- Ethics
- Events
- Family Medicine
- Gastroenterology
- Gene Therapy
- Geriatrics
- Gifts & Donations
- Home health care
- Immunology
- Infectious Diseases
- Innovation
- Integrative Medicine
- Leadership
- Medical devices
- Men's Health
- Mental Health
- Neurology
- Neurosurgery
- Nursing
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology
- Partnerships
- Pediatrics
- Physical therapy
- Podiatry
- Population Health
- Pulmonology
- Radiation oncology
- Radiology
- Rare Diseases
- Reproductive Health
- Research
- Respiratory disease
- Robotics
- Safety
- Sleep
- Sports Medicine
- Stroke
- Surgery
- Sustainability
- Technology
- Transplantation
- Urology
- Women's Health
-
Categories
- Cutler Center for Men
- Drusinsky Sports Medicine Institute
- Harrington Discovery Institute
- Harrington Heart & Vascular Institute
- Haslam Sports Innovation Center
- Nursing
- Rainbow Babies & Children's Hospital
- Seidman Cancer Center
- UH Transplant Institute
- UH Behavioral Health Institute
- UH Center for Orthopedics
- UH Community Hospitals
- UH Connor Whole Health
- UH Ear, Nose & Throat Institute
- UH Eye Institute
- UH Neurological Institute
- UH Primary Care Institute
- UH Research & Education Institute
- UH Urology Institute
- UH Ventures
Gene Therapy
Showing of 1 results
AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders
UH Harrington Discovery Institute included in partnership to create and fund new gene therapy company focused on inhaled gene therapy to treat rare respiratory diseases.
9/21/2023 By UH Media Relations
Results are loading...